7th RSC-BMCS / SCI Symposium on Ion Channels as Therapeutic Targets
Event
7th RSC-BMCS / SCI symposium on Ion Channels as Therapeutic Targets
Dates
Monday – Tuesday, 27th-28th March 2023
Place
Hinxton Hall, Wellcome Genome Campus, Cambridge
Important links and downloads
Handbook – click here
Twitter hashtag – #IonChannels23
First Announcement Poster available to view here
Second Announcement Poster available to view here
Synopsis
Ion channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting this gene family have been discovered for diseases such as hypertension, epilepsy and neuropathic pain. This symposium, the 7th in an ongoing series, will showcase the most recent advances to aid the design of new ion channel therapeutics and promote interaction between scientists with a shared interest in the field of ion channel drug discovery.
Who should attend
Scientists from industry and academia interested in the therapeutic potential of ion channels. The organising committee particularly welcomes attendance and participation of students or early career researchers working in the field of ion channels.
Call for Abstracts
The oral and poster deadline has now passed.
Registration
Registration is now closed. The Early-bird deadline is Monday 30th January 2023.
Registration fees will include the conference dinner. Limited on-site accommodation is available to book by following the instructions in your registration confirmationemail you will receive shortly after registering.
Student Bursaries
The RSC BMCS are offering some student bursaries to attend this meeting in person. Applications are now closed.
Programme
Monday 27th March
| 09:30 - 10:30 | Registration & Refreshments |
| 10:30 - 12:20 | Session 1: Chair - Professor Brian Cox, University of Sussex |
| 10:30 | Opening Remarks - Professor Brian Cox, University of Sussex |
| 10:40 - 11:15 | Professor Stephen Tucker, University of Oxford Defective gating underlies a novel K2P channelopathy associated with sleep apnea |
| 11:15 - 11:50 | Dr Michael Hahn, Bayer AG Pharmaceuticals Discovery of the TASK-1 and TASK-3 Channel Blocker BAY 2586116 for the Treatment of Obstructive Sleep Apnea (OSA) |
| 11:50 - 12:20 | Flash Oral Presentations |
| 12:20 - 13:30 | Lunch, exhibition and poster session |
| 13:30 - 14:45 | Session 2: Chair - Dr Nigel Swain, Sosei Heptares |
| 13:30 - 13:50 | Dr Alexandra Pinggera, Metrion Biosciences Dynamic action potential clamp to investigate ion channel pharmacology |
| 13:50 - 14:10 | Dr Damian Bell, Sophion Functional evaluation of snake neurotoxins and recombinant antibody antivenoms via automated patch clamp |
| 14:10 - 14:30 | Dr Anna Rowland, Cerevance Identification of THIK-1 as a therapeutic target for neuroinflammatory diseases: discovery and characterisation of a selective THIK-1 blocker |
| 14:30 - 14:50 | Dr Manuela Cerina, Eliem Therapeutics Discovery and characterisation of ETX-123, a novel Kv7.2/K7.3 activator for the treatment of Epilepsy |
| 14:50 - 15:20 | Refreshments, exhibition and poster session |
| 15:20 - 17:05 | Session 3: Chair - Dr Sarah Major, Evotec |
| 15:20 - 15:55 | Dr Anna Carbone, Evotec EVOchannel: tune in to safe molecules |
| 15:55 - 16:30 | Dr Alex Abela, Vertex Discovery of CFTR modulators for the treatment of Cystic Fibrosis |
| 16:30 - 17:05 | Dr Jose Maria Cid, Jansen R&D GluN2B PAMS as enhancers of synaptic plasticity for the treatment of Alzheimer´s disease |
| 17:05 - 19:00 | Networking reception and posters |
| 19:00 - 21:00 | Conference Dinner |
Tuesday 28th March
| 9:00 - 10:45 | Session 4: Chair - Dr Nadia Ahmad, Charles River Laboratories |
| 09:00 - 09:35 | Dr Mark Healy, Novartis The discovery of the NMDA receptor NR2B NAM, MIJ821, a novel, rapidly acting antidepressant |
| 09:35 - 10:10 | Dr Myriem El Qacemi, Syngenta The discovery of isocycloseram: a novel isoxazoline insecticide |
| 10:10 - 10:45 | Dr Giuseppe Cecere, F. Hoffmann-La Roche Ltd Discovery of First-in-Class Subtype Selective GABAA Alpha5 Positive Allosteric Modulators (PAMs) for the treatment of neurological disorders |
| 10:45 - 11:15 | Refreshments, exhibition and poster session |
| 11:15 - 13:00 | Session 5: Chair - Dr Mike Clegg, MSD |
| 11:15 - 11:50 | Dr Anna Junker, University of Muenster P2X ion channels as promising therapeutic and diagnostic targets: From the discovery of the first orthosteric P2X7R selective agonist to the development of optical probes for the imaging of P2X7R expression |
| 11:50 - 12:25 | Dr Simon Holton, Nuvisan Cryo-EM Structural Studies of The Human TRPV4 Ion-Channel |
| 12:25 - 13:00 | Dr Luca Raveglia, Evotec From High-Throughput Screening to Target Validation: Benzo[d]isothiazoles as Potent and Selective Agonists of Human TRPM5 Possessing In Vivo Gastrointestinal Prokinetic Activity in Rodents |
| 13:00 - 14:10 | Lunch, exhibition and poster session |
| 14:10 - 15:40 | Session 6: Chair - Sarah Major, Evotec |
| 14:10 - 14:20 | Poster Prize Presentation |
| 14:10 - 14:55 | Dr Steve Griffin, University of Leeds Plugging the holes in antiviral therapy – Drug discovery potential of viroporins to treat SARS-CoV2 |
| 14:55 - 15:30 | Dr Shawn Stachel, MSD Chemistry accelerated invention of a highly potent oral Nav1.8 channel blocker for the treatment of pain |
| 15:30 | Closing Remarks - Dr Sarah Major, Evotec |
| 15:40 | Meeting close |
Exhibitor Opportunity – Exhibitor Stands now fully booked!
The exhibitor package comprises-
– Stand space measuring 3 metres wide x 2 metres deep
– Table measuring 240cm wide x 80cm deep and chair
– Electrical and wifi access
– One stand personnel
– Your logo and full promotional page in the delegate handbook
– Your logo in the rolling slide, shown during the breaks
– Full attendance at the technical programme, poster sessions and conference evening dinner for stand personnel
£950.00 including one full delegate
£1,200 including two full delegates
Sponsor Opportunities
Sponsorship includes –
– Your logo in the pre-event announcements
– Your logo in the delegate handbook
– Your logo in the rolling slides, shown during the breaks
Minimum suggested sponsorship amount is £500.00
Sponsored Lanyards – £250.00
– Delegate lanyards with company logo, sponsor provides
Confirmed Sponsors
We are grateful to our confirmed sponsors for their valued support.
Confirmed Exhibitors
We are grateful to our confirmed exhibitors for their valued support.
Organising Committee
Karl Collins, Bayer Foundation (co-Treasurer)
Brian Cox, University of Sussex
Sarah Major, Evotec (Chair)
Nigel Swain, Sosei Heptares
Rose Bardell-Cox, Evotec (co-Treasurer)
Mike Clegg, MSD
Nadia Ahmad, Charles River Laboratories
Secretariat Contact
Hg3 Conferences Ltd
+44 (0)1423 529333
E-mail
